SCHEMBL5270945

SCHEMBL5270945

C[C@@H]1Cc2ccccc2[C@H]2CC[C@]3(C)[C@@H](CC(=O)OOC4CCCCO4)CC[C@H]3[C@H]12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.38
HSD11B1 P28845 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
ABCB1 P08183 1/20 0.33
ESR1 P03372 3/20 0.32
CYP3A4 P08684 2/20 0.32
LMNA P02545 2/20 0.32
PGR P06401 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
AR P10275 1/20 0.32
PTGS1 P23219 1/20 0.32
PDE4A P27815 1/20 0.32
PDE3A Q14432 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP2C19 P33261 1/20 0.32
HDAC3 O15379 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1659344 0.80 HSD11B1 (0.51) STSHSD11B1HRH3ESR1CYP3A4
SCHEMBL1656552 0.79 HSD11B1 (0.53) STSHSD11B1HRH3ESR1CYP3A4
SCHEMBL9747655 0.75 STS (0.47) STSHRH3ESR1HDAC3HDAC6
SCHEMBL2962921 0.74 STS (0.47) STSHRH3ESR1CYP3A4LMNA
SCHEMBL5273029 0.73 HSD11B1 (0.55) STSHSD11B1HRH3ESR1CYP3A4
SCHEMBL13216959 0.71 STS (0.51) STSHSD11B1HRH3ESR1CYP3A4
SCHEMBL27339223 0.70 AR (0.47) STSESR1CYP3A4LMNAPGR
SCHEMBL13216951 0.64 HSD11B1 (0.52) STSHSD11B1HRH3ESR1CYP3A4
SCHEMBL8081744 0.64 HSD11B1 (0.52) STSHSD11B1HRH3ESR1CYP3A4
SCHEMBL6462357 0.63 STS (0.54) STSHRH3ESR1CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1847548-A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Sri International (US) 2007-10-24 EP disclosed